Blenrep US Withdrawal Is A Big Blow To GSK’s Blockbuster Hopes

But A Comeback Remains Possible

 
• By Andrew McConaghie
  
US FDA entrance sign
The FDA is now enforcing the accelerated approval commitments more strictly, including requests for withdrawals. • Source: Sutterstock, JHVEPhoto
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip